Detection and Quantitation of Cannabinoids in Biological Fluids: Specificity and Kinetics after Smoking
- 1 January 1981
- journal article
- research article
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 18 (5) , 565-571
- https://doi.org/10.3109/15563658108990283
Abstract
A procedure for the quantitation and detection of cannabinoids in biological fluids (plasma and urine) was described. This method was based on isotopic derivatization and double labeling. .DELTA.9-Tetrahydrocannabinol [THC] and 2 metabolites (11-hydroxy-.DELTA.9-THC and 8-.beta.-hydroxy-.DELTA.9-THC) detected and measured in plasma or urine. Plasma was obtained from 2 morphine smoking addicts and urine was obtained from normal subjects, multiple drug addicts and hashish smokers. The use of TLC enabled specific separation of cannabinoids. The sensitivity of detection (4 ng/ml) was compatible with cannabinoid kinetics. This procedure can be applied to routine measurements and pharmacokinetic studies.This publication has 3 references indexed in Scilit:
- Detection and Quantitation of Δ9-Tetrahydrocannabinol in Plasma by Dansylation and Double LabelingPublished by American Chemical Society (ACS) ,1979
- Methodology for the detection and quantitation of -tetrahydrocannabinol in plasma by dansylation and double labellingClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Quantitation of Δ1-tetrahydrocannabinol in plasma from cannabis smokersJournal of Pharmacy and Pharmacology, 1973